$1.11
-0.02-2.19%
At close: -
$1.07
-0.04-4.04%
After Hours: Feb 25, 6:53 PM EDT
Comments
Loading...
Latest AN2 Therapeutics Stock News | NASDAQ:ANTX | Benzinga
Get the latest news on AN2 Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on AN2 Therapeutics performance
Categories: All
Tuesday, February 25, 2025
Monday, February 24, 2025
Monday, February 03, 2025
Tuesday, November 19, 2024
Monday, November 18, 2024
Wednesday, November 13, 2024
Thursday, October 17, 2024
Thursday, October 03, 2024
Monday, August 19, 2024
Friday, August 16, 2024
Thursday, August 15, 2024
Tuesday, August 13, 2024
Friday, August 09, 2024
- Crude Oil Rises; Blend Labs Shares Jump Following Q2 Results
- US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results
- Lung Disease Focused AN2 Therapeutics' Lackluster Data Prompts To Stop Phase 3 Study Of Lung Infection Candidate, Halves Workforce
- AN2 Therapeutics shares are trading lower aft...
- JMP Securities Maintains Market Outperform on...
Thursday, August 08, 2024
Wednesday, July 03, 2024
Friday, June 14, 2024
Thursday, May 16, 2024
Thursday, April 04, 2024
Tuesday, April 02, 2024
Monday, April 01, 2024
Thursday, March 28, 2024
Tuesday, February 13, 2024
Monday, February 12, 2024
- Nasdaq Edges Lower; ContextLogic Shares Surge
- Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Evercore ISI Group Downgrades AN2 Therapeutic...
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
- Oppenheimer Downgrades AN2 Therapeutics to Pe...
- JMP Securities Downgrades AN2 Therapeutics to...
- US Stocks Mixed; Trimble Issues Weak Outlook
- Why Is Infectious Disease-Focused AN2 Therapeutics Stock Sinking Today?
- AN2 Therapeutics shares are trading lower aft...
- Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- AN2 Therapeutics to Voluntarily Pause Enrollm...